Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01235624

NCT01235624
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with a condition called retinitis pigmentosa (an eye disease that causes gradual vision loss)
  • Your retinitis pigmentosa has been confirmed to be passed down through families in a pattern called "autosomal dominant" (meaning one parent with the condition can pass it to their child)
  • You are between 5 and 80 years old
  • You (or a parent/guardian if under 18) are willing and able to give consent to take part
  • You are covered by a health insurance plan or equivalent scheme

Who may not be able to join:

  • No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Montpellier
Registry
clinicaltrials_gov
Start date
1 March 2009
Est. completion
1 April 2013

Where this trial is recruiting

🇫🇷 France

Primary endpoints

identification of unknown loci and genes responsible of Autosomal dominant retinitis pigmentosa (adRP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov